Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the high-value drug profiling and therapeutic tissues markets
2017 Annual Report Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) - 0.02 (1.94%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $1.01 with a 52 week high of $3.26 and a 52 week low of $0.93.
Recent Investor News
Organovo Announces Fiscal Third-Quarter 2018 Results; Company Updates Full-Year Fiscal 2018 Outlook
Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results
Investor Events
There are currently no events scheduled.
Featured Reports
2017 Annual Report
2017 Proxy Statement
Latest Tweets
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet